Hantavirus ELISA Detection Guide

ELISA Assay Formats for Hantavirus Detection

Several ELISA formats have been developed for hantavirus serological diagnosis, each offering distinct advantages depending on the clinical question and laboratory setting. The three principal formats, indirect ELISA, IgM capture ELISA (MacCapture), and sandwich ELISA, differ in their antigen presentation strategy, detection antibody configuration, and the immunoglobulin class they target.

Indirect ELISA

The indirect ELISA format is the most widely used approach for hantavirus antibody screening. In this assay, recombinant hantavirus nucleocapsid (N) protein is coated onto polystyrene microplate wells as the capture antigen. Patient serum or plasma is added, and any hantavirus-specific antibodies present bind to the immobilized antigen. A species-specific secondary antibody conjugated with horseradish peroxidase (HRP) or alkaline phosphatase (AP) is then used for detection, followed by colorimetric substrate development.

Indirect ELISA offers practical advantages: it is simple to perform, highly sensitive for detecting both IgM and IgG antibodies when configured with class-specific secondary conjugates, and amenable to high-throughput screening in 96-well or 384-well formats.

IgM Capture ELISA (MacCapture)

The IgM capture ELISA, also known as MacCapture ELISA, is specifically designed for the detection of hantavirus-specific IgM antibodies, which are the earliest serological marker of acute infection. In this format, anti-human IgM antibodies are coated onto the microplate to capture all IgM from the patient sample, regardless of antigen specificity. Captured IgM is then probed with recombinant hantavirus antigen followed by an enzyme-labeled detector antibody specific for the viral antigen.

The MacCapture format provides superior specificity for acute-phase diagnosis compared to indirect ELISA because it eliminates false positives arising from rheumatoid factor (IgM anti-IgG complexes) and reduces competition between IgM and the typically more abundant IgG for antigen binding sites. Clinical evaluations have demonstrated that MacCapture ELISA achieves IgM detection sensitivities exceeding 95% within the first week of symptom onset for major pathogenic hantaviruses including Hantaan virus (HTNV), Puumala virus (PUUV), and Sin Nombre virus (SNV).

Sandwich ELISA for Antigen Detection

While most hantavirus ELISA applications focus on antibody detection, sandwich ELISA formats have also been explored for direct detection of viral antigens in clinical samples. This approach uses a capture antibody coated on the plate to bind hantavirus N protein from patient specimens, followed by a second detector antibody conjugated with an enzyme reporter. Antigen detection ELISA can potentially identify infections during the window period before antibody seroconversion, which typically spans the first three to seven days of illness.

However, antigen detection ELISA for hantaviruses has not achieved widespread clinical adoption due to the relatively low viral load in serum and plasma. Viremia in hantavirus infections is typically transient and peaks early, making timing critical.

Figure 2. Schematic representation of molecular diagnostic methods for hantavirus. ELISA serology complements molecular approaches for comprehensive case confirmation. (Romeo et al., 2025)

Antibody Kinetics and Diagnostic Window

Understanding the temporal dynamics of the antibody response is essential for interpreting ELISA results accurately. Hantavirus infection produces a characteristic serological profile that guides clinical decision-making.

IgM antibodies against hantavirus N protein typically become detectable by ELISA within two to five days after symptom onset, with near-universal seropositivity by day seven. IgM titers peak between weeks two and four and gradually decline, becoming undetectable in most patients within three to six months. The early appearance and short persistence of IgM make it the most reliable marker for diagnosing acute infection.

IgG antibodies emerge shortly after IgM and persist for years following infection. A confirmed case is typically defined by seroconversion from negative to positive IgM, a fourfold or greater rise in IgG titer between paired sera, or simultaneous detection of IgM and IgG in a clinically compatible patient.

Practical Considerations for ELISA Implementation

Sample Types and Timing

Hantavirus ELISA kits should be validated for serum, EDTA and heparin plasma, and cerebrospinal fluid. Early sample collection during the acute phase is critical for maximizing IgM detection sensitivity. A second convalescent-phase sample collected two to four weeks later demonstrates seroconversion or rising antibody titers, strengthening diagnostic confidence.

Automation and Throughput

For high-volume laboratories, ELISA kit compatibility with automated microplate processors is important. Key parameters include 96-well format compatibility, standardized reagent volumes, and stable colorimetric readouts. Automated systems reduce hands-on time and improve inter-assay reproducibility.

Quality Assurance and External Quality Assessment

Ongoing quality assurance is essential for maintaining ELISA diagnostic accuracy. Internal controls, including known positive and negative serum samples, should be run with each assay plate to monitor performance. Participation in external quality assessment (EQA) programs provides valuable inter-laboratory benchmarking and helps identify systematic errors or lot-to-lot reagent variability. Commercial hantavirus ELISA kits intended for in vitro diagnostic use must also meet regulatory requirements specific to the target market, including CE marking for Europe, FDA clearance for the United States, and relevant national registrations in endemic countries.

Figure 3. Surveillance workflow followed during hantavirus outbreaks, integrating ELISA serology with clinical and epidemiological assessment. (Romeo et al., 2025)